Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM

Diabetes

Volumn 46, Issue 11, 1997, Pages 1725-1732

  Kahn, Steven E ^a   Halban, Philippe A ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROINSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN RELEASE; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 0030662718     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1725     Document Type: Article

References (50)

1. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 45:242-256, 1996
2. Cohen RM, Nakabayashi T, Blix PM, Rue PA, Shoelson SE, Root MA, Frank BH, Revers RR, Rubenstein AH: A radioimmunoassay for circulating human proinsulin. Diabetes 34:84-91, 1985
3. Ward WK, Paquette TL, Frank BH, Porte D Jr: A sensitive radioimmunoassay for human proinsulin with sequential use of antisera to C-peptide and insulin. Clin Chem 32:728-733, 1986
4. Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulin. Biochem J 260:535-541, 1989
5. Duckworth WC, Kitabchi AE, Heinemann M: Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med 53:418-427, 1972
6. Gorden P, Hendricks CM, Roth J: Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetolagia 10:469-474, 1974
7. Mako ME, Starr JI, Rubenstein AH: Circulating proinsulin in patients with maturity-onset diabetes. Am J Med 63:865-869, 1977
8. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr: Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and experimental insulin resistance. Diabetologia 30:698-702, 1987
9. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
10. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet 1:293-295, 1989
11. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
12. Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte D Jr: Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab 74:192-197, 1992
13. Kahn SE, Horber FF, Prigeon RL, Haymond MW, Porte D Jr. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes 42:1082-1085, 1993
14. Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS: Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76:44-48, 1993
15. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN: Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32:689-693, 1990
16. Clark PM, Levy JC, Cox L, Burnett M, Turner RC, Hales CN: Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 35:469-474, 1992
17. Tillil H, Frank BH, Pekar AH, Broelsch C, Rubenstein AH, Polonsky KS: Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 127:2418-2222, 1990
18. Samols E, Bilkus D: A comparison of insulin immunoassays. Proc Soc Exp Biol Med 115:79-84, 1964
19. Morgan DR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115-126, 1963
20. Schnetzler B, Murakawa G, Abalos D, Halban PA, Selden R: Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of postranscriptional regulation. J Clin Invest 92:272-280, 1993
21. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1385, 1965
22. Vollenweider F, Irminger JC, Gross DJ, Villa-Komaroff L, Halban PA: Processing of proinsulin by transfected hepatoma (FAO) cells. J Biol Chem 267:14629-14636, 1992
23. Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH: Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism 35:1137-1146, 1986
24. Gross D, Skvorak A, Hendrick G, Weir G, Villa-Komaroff L, Halban PA: Oxidation of rat insulin II, but not I, leads to anomalous elution profiles upon HPLC analysis of insulin-related peptides. FEBS Lett 241:205-208, 1988
25. Sizonenko SV, Halban PA: Differential rates of conversion of rat proinsulins I and II: Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II. Biochem J 278:621-625, 1991
26. Sizonenko S, Irminger JC, Buhler L, Deng S, Morel P, Halban PA: Kinetics of proinsulin conversion in human islets. Diabetes 42:933-936, 1993
27. Irminger JC, Vollenweider FM, Neerman-Arbez M, Halban PA: Human proinsulin conversion in the regulated and the constitutive pathway of transfected AtT20 cells. J Biol Chem 269:1756-1762, 1994
28. Davidson HW, Rhodes CJ, Hutton JC: Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β-cell via two distinct site-specific endopeptidases. Nature 333:93-96, 1988
29. DeFronzo RA: Glucose intolerance of aging: evidence for tissue insensitivity to insulin. Diabetes 28:1095-1101, 1979
30. Olefsky JM, Kolterman OG, Scarlett JA: Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243:E15-E30, 1982
31. Halban PA: Proinsulin conversion intermediates: a possible source of confusion (Letter). Diabetologia 34:202-203, 1991
32. Rhodes CJ, Lincoln B, Shoelson SE: Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase: implication of a favored route for prohormone processing. J Biol Chem 267:22719-22727, 1992
33. Kahn SE, Leonetti DL, Prigeon RL, Bergstrom RW, Fujimoto WY: Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese American men: impact of obesity. J Clin Endocrinol Metab 80:1399-1406, 1995
34. Haffner SM, Bowsher RR, Mykkanen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, Stern MP: Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 43:1490-1493, 1994
35. Bowsher RR, Wolny JD, Frank BH: A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 41:1084-1090, 1992
36. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414, 1988
37. Leahy JL, Halban PA, Weir GC: Relative hypersecretion of proinsulin in rat model of NIDDM. Diabetes 40:985-989, 1991
38. Bonner-Weir S, Trent DF, Honey RN, Weir GC: Responses of neonatal islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30:64-69, 1981
39. Thorens B, Weir GC, Leahy JL, Lodish HF, S. B-W: Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc Natl. Acad Sci U S A 87:6492-6496, 1990
40. Leahy JL, Weir GC: Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia Diabetes 37:217-222, 1988
41. Leahy JL: Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes 42:22-27, 1993
42. Gadot M, Leibowitz G, Shafrir E, Cerasi E, Gross DJ, Kaiser N: Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus. Endocrinology 135:610-616, 1994
43. Leahy JL, Bonner-Weir S, Weir GC: Beta-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442-455, 1992
44. Gadot M, Ariav Y, Cerasi E, Kaiser N, Gross DJ: Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell. Endocrinology 136:4218-4223, 1995
45. Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ: Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non insulin dependent diabetes mellitus. J Clin Invest 95:1032-1039, 1995
46. Halban PA, Irminger JC: Sorting and processing of secretory proteins. Biochem J 299:1-18, 1994
47. Vollenweider F, Kaufmann J, Irminger JC, Halban PA: Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes 44:1075-1080, 1995
48. Neerman-Arbez M, Sizonenko SV, Halban PA: Slow cleavage at the proinsulin B-chain/connecting peptide junction associated with low levels of endoprotease PC1/3 in transformed beta cells. J Biol Chem 268:16098-16100, 1993
49. Neerman-Arbez M, Cirulli V, Halban PA: Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. Biochem J 300:57-61, 1994
50. Irminger JC, Meyer K, Halban P: Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochem J 320:11-15, 1996